SUDARSHAN PHARMA INDUSTRIES
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.66 | 4.76 | 2.92 | 5.38 | 2.80 |
| CEPS(Rs) | 0.76 | 0.53 | 0.33 | 0.63 | 0.36 |
| DPS(Rs) | - | - | 0.30 | - | - |
| Book NAV/Share(Rs) | 5.30 | 46.42 | 41.96 | 30.54 | 23.58 |
| Tax Rate(%) | 26.24 | 24.78 | 25.90 | 26.44 | 25.27 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 7.90 | 4.92 | 3.18 | 3.06 | 3.71 |
| EBIT Margin(%) | 7.41 | 5.21 | 3.23 | 2.94 | 3.52 |
| Pre Tax Margin(%) | 4.28 | 3.29 | 2.06 | 2.00 | 1.85 |
| PAT Margin (%) | 3.16 | 2.47 | 1.53 | 1.47 | 1.38 |
| Cash Profit Margin (%) | 3.60 | 2.74 | 1.72 | 1.71 | 1.77 |
| Performance Ratios | |||||
| ROA(%) | 4.65 | 4.44 | 3.80 | 4.43 | 2.69 |
| ROE(%) | 13.33 | 10.77 | 10.76 | 20.08 | 11.87 |
| ROCE(%) | 14.42 | 13.75 | 15.25 | 18.67 | 13.01 |
| Asset Turnover(x) | 1.47 | 1.80 | 2.49 | 3.02 | 1.95 |
| Sales/Fixed Asset(x) | 17.05 | 17.90 | 29.82 | 44.28 | 25.32 |
| Working Capital/Sales(x) | 6.72 | 6.04 | 5.76 | 13.25 | 11.77 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.06 | 0.06 | 0.03 | 0.02 | 0.04 |
| Receivable days | 102.16 | 80.34 | 61.31 | 68.42 | 114.01 |
| Inventory Days | 81.75 | 63.12 | 48.04 | 36.20 | 45.24 |
| Payable days | 62.07 | 64.12 | 70.18 | 64.25 | 90.88 |
| Valuation Parameters | |||||
| PER(x) | 46.06 | 1.56 | 19.08 | - | - |
| PCE(x) | 40.44 | 14.04 | 16.90 | - | - |
| Price/Book(x) | 5.76 | 1.60 | 1.33 | - | - |
| Yield(%) | - | - | 0.54 | - | - |
| EV/Net Sales(x) | 1.79 | 0.61 | 0.34 | 0.11 | 0.20 |
| EV/Core EBITDA(x) | 21.33 | 11.14 | 9.91 | 3.52 | 5.05 |
| EV/EBIT(x) | 24.20 | 11.71 | 10.52 | 3.81 | 5.60 |
| EV/CE(x) | 3.00 | 1.31 | 1.16 | 0.66 | 0.73 |
| M Cap / Sales | 1.46 | 0.38 | 0.29 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.95 | 0.48 | 29.19 | 84.69 | - |
| Core EBITDA Growth(%) | 66.97 | 60.81 | 38.88 | 50.89 | - |
| EBIT Growth(%) | 54.72 | 62.25 | 41.69 | 54.63 | - |
| PAT Growth(%) | 39.26 | 62.79 | 34.07 | 96.49 | - |
| EPS Growth(%) | -86.07 | 62.80 | -45.68 | 92.34 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.34 | 0.94 | 0.34 | 1.03 | 1.32 |
| Current Ratio(x) | 1.29 | 1.48 | 1.68 | 1.26 | 1.23 |
| Quick Ratio(x) | 0.75 | 0.94 | 1.05 | 0.81 | 0.89 |
| Interest Cover(x) | 2.37 | 2.70 | 2.76 | 3.11 | 2.11 |
| Total Debt/Mcap(x) | 0.23 | 0.59 | 0.25 | - | - |
Compare Financial Ratios of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,005.5 Cr | 4.9% | 19.1% | 35.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 4.9% |
19.1% |
35.3% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses
